The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (6.00) USD. With the latest stock price at 0.58 USD, the upside of Cytosorbents Corp based on DCF is -1128.4%.
Based on the latest price of 0.58 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 1128.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.6% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (16.41) - (3.83) | (6.00) |
| Upside | -2914.0% - -757.3% | -1128.4% |